This site is intended for healthcare professionals only
LoginRegister
AstraZeneca to Invest USD 15 Billion in China by 2030AstraZeneca gets CDSCO Panel Nod to study asthma drug Benralizumab
Lupin buys five brands from MenariniLupin buys five brands from Menarini
HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuitEMA Committee grants positive opinion for Veklury use to treat COVID 19 in people with Hepatic...
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaAstraZeneca rare disease unit acquires Pfizer portfolio for USD 1 billion
Alkem Binding Offer to Acquire Stake in OcclutechAlkem Labs brands API business as Alkem Activa
Glenmark Pharma to divest 75 percent stake in Glenmark Life Sciences to Nirma for Rs 5651 croreGlenmark Pharma to divest 75 percent stake in Glenmark Life Sciences to Nirma for Rs 5651 crore
Budget Quotes - Mankind Pharma, Bharat Serum and Vaccines & Park Medi WorldCDSCO panel rejects Mankind Pharma's Proposal to Study Dydrogesterone Tablets Kit
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaMerck gets USFDA priority review for Keytruda plus concurrent chemoradiotherapy for cervical cancer
India to mandate annual audit of pharma suppliers by drugmakersIndia to mandate annual audit of pharma suppliers by drugmakers
USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas PharmaPfizer Litfulo gets European Commission approval for adolescents, adults with severe alopecia areata
Merck Welireg get USFDA priority review for certain previously treated patients with Advanced Renal Cell CarcinomaMerck Welireg get USFDA priority review for certain previously treated patients with Advanced Renal...
Biocon unveils Liraglutide for diabetes, obesity in NetherlandsBiocon Biologics gets European Commission nod for critical eye treatment medicine Yesafili
X